Literature DB >> 19101003

Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages.

Emilie Maurais1, Réjean Cantin, Michel J Tremblay.   

Abstract

CD40 ligand (CD40L) is mainly expressed in activated CD4(+)T cells and interacts with CD40 on antigen-presenting cells to regulate both humoral and cellular immune responses. We previously reported that CD40L is acquired by emerging HIV-1 particles. Here we demonstrate that both wild-type and a non-functional mutated form of CD40L are incorporated within HIV-1. Importantly, we show that wild-type CD40L remains functional since CD40L-bearing virions mediate NF-kappaB activation in a CD40-expressing reporter cell line and induce secretion of the chemokine IL-8 by monocyte-derived macrophages. These results suggest a possible means exploited by HIV-1 to attract susceptible target cells to the site of infection, a process that might promote viral dissemination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101003     DOI: 10.1016/j.virol.2008.11.033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

Authors:  Sachin Gupta; James M Termini; Liguo Niu; Saravana K Kanagavelu; Helena Schmidtmayerova; Victoria Snarsky; Richard S Kornbluth; Geoffrey W Stone
Journal:  J Leukoc Biol       Date:  2011-05-17       Impact factor: 4.962

2.  Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Authors:  M-A Jenabian; M Patel; I Kema; K Vyboh; C Kanagaratham; D Radzioch; P Thébault; R Lapointe; N Gilmore; P Ancuta; C Tremblay; J-P Routy
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

3.  A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.

Authors:  Sachin Gupta; James M Termini; Yaelis Rivas; Miguel Otero; Francesca N Raffa; Vikas Bhat; Amjad Farooq; Geoffrey W Stone
Journal:  Vaccine       Date:  2015-08-01       Impact factor: 3.641

4.  Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.

Authors:  Sachin Gupta; James M Termini; Francesca N Raffa; Cindi-Ann Williams; Richard S Kornbluth; Geoffrey W Stone
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

5.  A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.

Authors:  Mark Melchers; Katie Matthews; Robert P de Vries; Dirk Eggink; Thijs van Montfort; Ilja Bontjer; Carolien van de Sandt; Kathryn David; Ben Berkhout; John P Moore; Rogier W Sanders
Journal:  Retrovirology       Date:  2011-06-20       Impact factor: 4.602

6.  Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction.

Authors:  Norbert Donhauser; Kathrin Pritschet; Martin Helm; Thomas Harrer; Philipp Schuster; Moritz Ries; Georg Bischof; Jörg Vollmer; Sigrun Smola; Barbara Schmidt
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

7.  Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.

Authors:  James M Termini; Sachin Gupta; Francesca N Raffa; Elizabeth Guirado; Margaret A Fischl; Liguo Niu; Saravana Kanagavelu; Geoffrey W Stone
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

8.  Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.

Authors:  Sachin Gupta; James M Termini; Biju Issac; Elizabeth Guirado; Geoffrey W Stone
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

Review 9.  The Incorporation of Host Proteins into the External HIV-1 Envelope.

Authors:  Jonathan Burnie; Christina Guzzo
Journal:  Viruses       Date:  2019-01-20       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.